These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12867216)

  • 1. Gabapentin dosing in the treatment of epilepsy.
    McLean MJ; Gidal BE
    Clin Ther; 2003 May; 25(5):1382-406. PubMed ID: 12867216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin.
    Morris GL
    Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin in the management of convulsive disorders.
    McLean MJ
    Epilepsia; 1999; 40 Suppl 6():S39-50; discussion S73-4. PubMed ID: 10530682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.
    Backonja M; Glanzman RL
    Clin Ther; 2003 Jan; 25(1):81-104. PubMed ID: 12637113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin: a new agent for the management of epilepsy.
    Andrews CO; Fischer JH
    Ann Pharmacother; 1994 Oct; 28(10):1188-96. PubMed ID: 7841578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid initiation of gabapentin: a randomized, controlled trial.
    Fisher RS; Sachdeo RC; Pellock J; Penovich PE; Magnus L; Bernstein P
    Neurology; 2001 Mar; 56(6):743-8. PubMed ID: 11274308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety.
    Korn-Merker E; Borusiak P; Boenigk HE
    Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
    McLean MJ; Morrell MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus-Miller L; Bernstein P; Rose-Legatt A
    Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.
    Goa KL; Sorkin EM
    Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing to efficacy with neurontin: the STEPS trial. Study of Titration to Effect Profile of Safety.
    Morrell MJ
    Epilepsia; 1999; 40 Suppl 6():S23-6; discussion S73-4. PubMed ID: 10530679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin.
    McLean MJ
    Epilepsia; 1995; 36 Suppl 2():S73-86. PubMed ID: 8784216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies.
    Trudeau V; Myers S; LaMoreaux L; Anhut H; Garofalo E; Ebersole J
    J Child Neurol; 1996 Nov; 11(6):470-5. PubMed ID: 9120226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (2):CD001415. PubMed ID: 10796785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
    Handforth A; Treiman DM
    Epilepsia; 1994; 35(5):1032-7. PubMed ID: 7925148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E
    Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
    Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.